Given that mutations of the tumor suppressor p53 are present in two-thirds of low grade astrocytomas, it is not surprising that p53 is the predominant genetic aberration in secondary glioblastomas (~60%) [26–28]. The gene discussed is TP53; the disease is astrocytoma (excluding glioblastoma).